Nanoemulsions as a formulation approach for topicals

By |2025-09-22T18:04:34+02:0011. February 2025|Corporate, Pharma|

Penetrating the skin barrier and ensuring the bioavailability of active ingredients, as well as their protective capacity, are considered to be major challenges in the development of topical dosage forms.

Comments Off on Nanoemulsions as a formulation approach for topicals

From Earth into space: MIGLYOL® 812 N takes off

By |2025-04-02T14:06:55+02:0028. January 2025|Pharma, Pharma|

Recently, our MIGLYOL® 812 N has taken off: the Technical University of Darmstadt asked us to provide samples for experiments on board the International Space Station (ISS). This literally takes our MIGLYOL® into new spheres! It is an inspiring thought that our MIGLYOL® is not only used on Earth, but [...]

Comments Off on From Earth into space: MIGLYOL® 812 N takes off

Decades of expertise in the field of application technology – The Product Development (PD) department of IOI Oleo GmbH

By |2025-09-22T18:04:35+02:0025. October 2024|Corporate, Pharma|

IOI Oleo GmbH is known for its high-quality oleochemical specialities and the technical advice it provides on the use of its products. Thanks to its diversity and longstanding reliability, the product portfolio is used in the pharmaceutical, care, nutrition and technical applications sectors. The R&PD team and its expertise in [...]

Comments Off on Decades of expertise in the field of application technology – The Product Development (PD) department of IOI Oleo GmbH

The R&D department of IOI Oleo GmbH supports you – from the idea to the first product

By |2025-09-22T18:04:36+02:0021. August 2024|Corporate, Pharma|

As a leading company in the field of speciality lipids and pharmaceutical oleochemicals, IOI Oleo GmbH develops innovative and sustainable processes, products and formulations at its research centre in Witten.

Comments Off on The R&D department of IOI Oleo GmbH supports you – from the idea to the first product

Trust and transparency – IMWITOR® 742 now with CEP

By |2025-03-25T15:58:05+01:008. July 2024|Pharma|

Product lifecycle management (PLM) for pharmaceuticals ties up considerable capacities in the quality and regulatory departments over the entire lifecycle of the marketing authorisation. Efficient management of information relevant for the authorisation of newly developed, reformulated and generic medicinal products is therefore a significant success factor. In particular, change notifications [...]

Comments Off on Trust and transparency – IMWITOR® 742 now with CEP

Our debut as an exhibitor at CPHI China

By |2025-03-25T15:58:07+01:0021. May 2024|Pharma|

In recent years, we have strategically strengthened our presence in the future-oriented Asian market: we have entered into new distribution partnerships and participated in numerous trade fairs. Together with our Chinese partner Beijing Fengli, we are now exhibiting at CPHI 2024 in Shanghai, emphasising our commitment to this dynamic and [...]

Comments Off on Our debut as an exhibitor at CPHI China

Core competence innovation: The R&D department of IOI Oleo GmbH

By |2025-09-22T18:04:36+02:001. April 2024|Nutrition, Personal Care, Pharma, Technical Applications|

IOI Oleo GmbH is known for its high-quality oleochemical specialties and is regarded as a benchmark in many areas. To achieve and maintain this status, continuous work on existing products and innovations is required, as market requirements are changing rapidly. For this reason, we have built up a 14-strong R&D [...]

Comments Off on Core competence innovation: The R&D department of IOI Oleo GmbH

Quality & continuity – The importance of consistently high quality of excipients and raw materials

By |2025-04-02T14:07:45+02:001. March 2024|Pharma, Pharma, Trade Fairs|

We warmly invite you to visit our booth 29 in the exhibition area of the Austria Center Vienna from March 18 to 21, 2024 and talk directly to our team of experts from R&D, Regulatory and Galenics.

Comments Off on Quality & continuity – The importance of consistently high quality of excipients and raw materials

Regulatory innovations – Milestones for the Chinese market – IMWITOR® 742, MIGYLOL® 810 N & MIGLYOL® 812 N

By |2024-01-30T11:01:43+01:0030. January 2024|Pharma|

The filing of two further dossiers with the Chinese NMPA* represents an outstanding milestone for customers in the Chinese market. From now on, manufacturers and exporters of finished pharmaceutical products can refer to these dossiers in their application documents. Our Regulatory Affairs department will issue your "Letter of Access" on [...]

Comments Off on Regulatory innovations – Milestones for the Chinese market – IMWITOR® 742, MIGYLOL® 810 N & MIGLYOL® 812 N

CEP 2.0 completely new? Effects on the quality and layout of the certificate

By |2025-03-25T15:58:10+01:006. December 2023|Pharma|

The high quality that we strive for in our portfolio is also reflected in our service. One aspect of this service is to make the usage of our excipients as simple and safe as possible; hence, we have selected products certified by the "European Directorate for the Quality of Medicines [...]

Comments Off on CEP 2.0 completely new? Effects on the quality and layout of the certificate
Go to Top
Kontakt